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The remodeling of maternal uterine spiral arteries (SAs) is an essential process for ensuring low-resistance, 
high-capacitance blood flow to the growing fetus. Failure of SAs to remodel is causally associated with pre-
eclampsia, a common and life-threatening complication of pregnancy that is harmful to both mother and 
fetus. Here, using both loss-of-function and gain-of-function genetic mouse models, we show that expression 
of the pregnancy-related peptide adrenomedullin (AM) by fetal trophoblast cells is necessary and sufficient to 
promote appropriate recruitment and activation of maternal uterine NK (uNK) cells to the placenta and ulti-
mately facilitate remodeling of maternal SAs. Placentas that lacked either AM or its receptor exhibited reduced 
fetal vessel branching in the labyrinth, failed SA remodeling and reendothelialization, and markedly reduced 
numbers of maternal uNK cells. In contrast, overexpression of AM caused a reversal of these phenotypes with a 
concomitant increase in uNK cell content in vivo. Moreover, AM dose-dependently stimulated the secretion of 
numerous chemokines, cytokines, and MMPs from uNK cells, which in turn induced VSMC apoptosis. These 
data identify an essential function for fetal-derived factors in the maternal vascular adaptation to pregnancy 
and underscore the importance of exploring AM as a biomarker and therapeutic agent for preeclampsia.
Introduction
It is widely accepted that the placenta provides the venue for com-
munication between the mother and fetus and that this commu-
nication is essential for their continued health throughout preg-
nancy. During midgestation, the maternal uterine spiral arteries 
(SAs) must provide increasing amounts of oxygen and nutrients to 
the growing fetus, and so they undergo active remodeling in order 
to transform into low-resistance, high-capacitance blood vessels. 
SA remodeling is a complex event that involves several distinct pro-
cesses: (a) endothelial cell vacuolization and relaxation of VSMCs 
that lead to arterial dilation and growth, (b) induction of local pla-
cental factors, including MMPs, chemokines, and cytokines, which 
in turn cause (c) dissolution of the ECM, (d) dedifferentiation and 
apoptosis of VSMCs, and (e) replacement of VSMCs by invasive 
fetal trophoblast cells (1–5). Considering the complexity of this 
process, it is not surprising that preeclampsia — a life-threatening 
pregnancy complication caused by poor SA remodeling — is so 
prevalent and detrimental to both mother and fetus (6, 7). Since the 
fetus is the primary beneficiary of increased blood flow, it stands 
to reason that fetal signals may play an active role in enabling SA 
remodeling. However, very few fetal-derived trophoblast factors 
involved in SA remodeling have been identified (8–11).
On the other hand, maternal uterine NK (uNK) cells, which do 
not exhibit the cytotoxic behavior of peripheral NK cells, are known 
to be required for SA remodeling (4, 11, 12). uNK cells are the most 
abundant of all decidual leukocytes, accounting for approximately 
70% of CD45+ cells, and are histologically identified by large cyto-
plasmic granules containing perforin and granzymes (1). uNK 
cells, which are transiently present in the decidua, are frequently 
aggregated around SAs and play a functional role in remodeling 
(12–14). Pioneering studies by Croy and colleagues have demon-
strated that the SAs of transgenic mice that lack uNK cells show 
a persistence of VSMCs surrounding un-dilated SAs (1, 15, 16). 
Only very recently have sophisticated techniques for the isolation 
and enrichment of uNK cells permitted more in-depth evaluation 
of these cells (17, 18). uNK cells secrete a wide variety of growth 
factors, chemokines, cytokines, and MMPs (4) and thus represent 
a major constituent of the innate immune milieu of the placen-
ta. Several recent studies have begun to reveal important patho-
physiological roles for uNK cells in human pregnancy (19–22). 
However, much remains unknown about the precise molecular 
interactions between fetal trophoblast cells and uNK cells in the 
placenta. It is also unclear whether perturbations in this fetal-to-
maternal communication can account for, or be diagnostic of, 
failed SA remodeling and preeclampsia.
Adrenomedullin (Adm; encoding AM) is a hypoxia-induced, 
angiogenic peptide vasodilator that is elevated approximately 
5-fold in the maternal plasma of normal human pregnancies, 
but often blunted in pregnancies complicated by preeclampsia 
(23). Moreover, the direct transcriptional induction of Adm gene 
expression (and that of its receptor components) by estrogen 
confers high levels of this peptide signaling pathway in female 
reproductive organs, including the ovaries, uterus, uterine arter-
ies, and placenta (24–27). Yallampalli and colleagues showed that 
systemic administration of an AM antagonist during late rat gesta-
tion caused a myriad of pregnancy abnormalities, including fetal 
growth restriction, placental and fetal membrane necrosis, and 
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fetal edema (28). While the AM antagonist did not change mater-
nal systemic blood pressure, it is likely that many of these feto-
placental sequelae developed as a consequence of acutely reduced 
uterine perfusion (29).
Using gene-targeted mice, we previously showed that full expres-
sion of maternal Adm is required for the early establishment of 
pregnancy and placentation: modest haploinsufficiency for mater-
nal Adm caused poor uterine receptivity, reduced pinopode for-
mation, and subfertility, even when WT embryos were transferred 
to the uterus (30). Consequently, pregnant Adm+/– females exhibit 
abnormal implantation, ectopic placentation, and fetal growth 
restriction that results in a wave of embryonic lethality around 
E9.5 that is largely independent of fetal genotype (31). These find-
ings highlight the importance of maternal Adm genetic dosage 
during the early stages of pregnancy, yet the function of fetal Adm 
expression during pregnancy remains unclear.
Here, using both loss-of-function and gain-of-function genetic 
mouse models, we showed that expression of Adm and its G pro-
tein–coupled receptor by fetal trophoblast cells was necessary and 
sufficient to promote appropriate recruitment and activation of 
maternal uNK cells to the placenta and ultimately facilitate the 
remodeling of maternal SAs.
Results
Adm-null placentas exhibit parietal trophoblast giant cell death and 
reduced labyrinth vessel branching. We previously showed that Adm is 
expressed in trophectoderm cells of the preimplantation blastocyst 
and that its expression is increased when trophoblast stem cells are 
differentiated into the giant cell lineage (31). Using in situ hybrid-
ization, we found that this robust expression was maintained 
in vivo within fetal parietal trophoblast giant cells (TGCs; poly-
ploidy derivatives of the primary mural trophectoderm cells that 
line the implantation site; refs. 32–34) at E9.5 and E13.5 (Figure 1, 
A–C), consistent with previous studies (35). There was also strong 
expression of Adm surrounding the invading ectoplacental cone 
at E9.5 and at the innermost border of the maternal-fetal interface 
(Figure 1, A and B). Adm expression persisted in TGCs at E13.5, 
and stromal cells of the maternal decidua expressed moderate lev-
els of Adm (Figure 1C). The chorionic plate, embryo, fetal mem-
branes, labyrinth, and spongiotrophoblast-containing junctional 
zone expressed little to no Adm.
Although Adm–/– mice die at midgestation with lymphatic vas-
cular defects (36), we wondered whether genetic dosage of fetal 
Adm could also contribute to pregnancy outcomes. Histologi-
cal and morphometric analyses showed that Adm–/– placentas 
appeared overtly normal, with well-formed layers and labyrinth 
thickness that were indistinguishable from those of Adm+/+ litter-
mates (Figure 1D and Supplemental Figure 1; supplemental mate-
rial available online with this article; doi:10.1172/JCI67039DS1). 
Because a hallmark function of AM peptide is vasodilation, some 
have speculated that its expression in placenta may be associated 
with maintaining low-resistance blood flow through the placental 
vasculature and umbilical cord (37). Contrary to this hypothesis, 
we found that loss of Adm had no effect on placental impedance, 
as calculated by umbilical cord blood flow using in vivo Doppler 
ultrasound (Supplemental Figure 2).
Despite their overtly normal appearance and function, E13.5 
Adm–/– placentas had a prominent band of apoptosing cells that 
spatially localized to the innermost border of the maternal-fetal 
interface (Figure 1E), where Adm-expressing parietal TGCs are 
located, which suggests that AM is an essential survival factor 
for these cells. Consistent with this finding, qRT-PCR analysis 
of trophoblast marker genes revealed that Adm–/– placentas had 
significantly reduced expression of placental lactogen 1 — a spe-
cific marker of parietal TGCs — while the expression of other 
TGC lineage markers and spongiotrophoblast markers did not 
differ significantly from that of WT placentas (Supplemental 
Figure 3). Even though Adm is not abundantly expressed in the 
Figure 1
Fetal loss of Adm causes trophoblast apoptosis at the maternal-fetal 
interface. (A) In situ hybridization of Adm gene expression in WT E9.5 
mouse placentas, revealing robust expression in parietal TGCs. (B) 
Digital zoom of boxed region in A (enlarged ×2-fold), showing punctu-
ate Adm staining in TGCs lining the ectoplacental cone (epc) at the 
innermost border of the maternal-fetal interface and little to no expres-
sion in the chorionic plate (cp), embryo (emb), or fetal membranes 
(fm). (C) Adm expression persisted in TGCs at E13.5 (arrows) and was 
diffusely expressed in stromal cells throughout the maternal decidua 
(de). The labyrinth (lb) and spongiotrophoblast-containing junctional 
zone (jz) expressed little to no Adm. (D) H&E staining of placentas 
from Adm+/+ and Adm–/– littermates revealed largely normal structures, 
with no difference in the thickness of the labyrinth layer (Supplemental 
Figure 1). Digital zoom of central part of placentas is shown at the right 
of each image (enlarged ×1.5-fold). (E) TUNEL staining of placentas 
from Adm+/+ and Adm–/– littermates showed a prominent band of apop-
tosing cells in Adm–/– placentas that colocalized to TGC location and 
correlated with the high level of Adm expression in these cells. For bet-
ter clarity and data presentation, the original colors from the captured 
images in E were inverted using Adobe Photoshop. Original magnifica-
tion, ×4 (A–C). Scale bars: 1 mm (D); 500 μM (E).
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labyrinth, we also found a modest, yet significant, reduction in 
the labyrinth-expressing genes Gcm1, JunB, and Gab1 (Supple-
mental Figure 3).
Further characterization of the labyrinth layer showed marked 
defects in the vascular patterning of fetal vessels in Adm–/– placentas. 
Isolectin B4 staining of the ECM surrounding fetal labyrinth vessels 
revealed a highly branched network in Adm+/+ placentas, but abnor-
mally large and underbranched fetal vessels in Adm–/– placentas 
(Figure 2A). Using nucleated and non-nucleated blood cells as mark-
ers for fetal and maternal blood sinuses, respectively, we performed 
quantitative morphometric analysis of the labyrinth vasculature 
(Figure 2B). Consistent with our finding of normal labyrinth thick-
ness and normal placental impedance, the total area of vascular 
space in Adm–/– labyrinth did not differ from that in Adm+/+ placen-
tas (Figure 2C). However, we found that individual fetal sinuses of 
Adm–/– placentas were significantly larger than those of Adm+/+ pla-
centas (P < 0.01; Figure 2D). This increase in the size of fetal sinuses 
was accompanied by a concomitant reduction in the size of mater-
nal sinuses in Adm–/– versus Adm+/+ placentas (P < 0.02; Figure 2D).
To better visualize the architecture and structure of the laby-
rinth vasculature, we made vascular corrosion casts of the pla-
centas by perfusing pregnant female mice with a liquid polymer. 
Fetal placental tissue was enzymatically digested away from the 
hardened maternal casts in order to reveal the interdigitation of 
maternal and fetal vasculature within the labyrinth placentas of 
Adm+/+ and Adm–/– littermates. Therefore, in the scanning electron 
micrographs of Figure 2, E and F, the open spaces represent the 
footprint of the fetal vasculature as it was interdigitated between 
the maternal blood sinuses within the central labyrinth layer. 
Adm–/– placentas had large holes (Figure 2E, arrowheads) and 
higher-magnification views demonstrated vast spacing between 
the maternal sinuses (Figure 2F), reflective of the large and under-
branched phenotype of Adm–/– fetal vessels. Taken together, these 
data demonstrated a failure of fetal vessels to branch appropri-
ately in Adm–/– placentas.
Because shallow invasion of chorionic villi can lead to blunted 
fetal vascular branching, we used alkaline phosphatase staining 
to evaluate the extent of chorionic villus formation and found no 
significant difference between WT and Adm–/– placentas (integrat-
ed density, Adm+/+, 11.8 ± 2.0 AU; Adm–/–, 11.3 ± 2.0 AU; Figure 2G). 
This finding demonstrated that the fetal vascular branching 
defects of Adm–/– placentas were inherent to the fetal vasculature, 
rather than secondary to defects in chorionic villus invasion or 
formation. Collectively, the data presented in Figures 1 and 2 
Figure 2
Reduced branching of fetal labyrinth vessels in Adm–/– placentas. (A) Isolectin B4 staining revealed a highly branched network in Adm+/+ pla-
centas, in contrast to abnormally large and underbranched fetal vessels in Adm–/– placentas. (B) Fetal (blue) and maternal (red) blood sinuses 
demarcated within the labyrinth layer. (C) Quantitative morphometric analysis of total sinus space per field. (D) Quantitation of individual sinus 
area revealed that fetal sinuses of Adm–/– placentas were significantly larger than those of Adm+/+ placentas, with a concomitant reduction in size 
of maternal sinuses. n = 12 placentas per genotype. *P < 0.02; #P < 0.01. (E and F) Scanning electron microscopy of vascular corrosion casts of 
maternal placental vasculature, at low power (E) and higher magnification (F). The large holes (white arrows) were indicative of large fetal vessels. 
Images are representative of n = 4 placentas per genotype. (G) Alkaline phosphatase staining of labyrinth revealed no structural or quantitative 
differences in chorionic villus cells. Data are mean ± SEM. Scale bars: 50 μM (A, B, and G); 1 mm (E); 100 μM (F).
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showed that compared with those of their WT littermates, Adm–/– 
placentas exhibited increased apoptosis of parietal trophoblast 
cells accompanied by reduced fetal vessel branching.
Failed SA remodeling and reduced uNK cells in Adm-null placentas. 
Because several clinical studies have shown that maternal levels of 
AM are reduced in preeclampsia (23), we evaluated another char-
acteristic pathology of preeclampsia in Adm–/– placentas: remodel-
ing of maternal SAs. As expected, SAs of WT placentas progres-
sively lost staining for SMA as they approached the maternal-fetal 
interface (Figure 3A). In contrast, SAs from Adm–/– placentas 
retained a thick smooth muscle layer throughout the decidua that 
was nearly twice the thickness measured in WT placentas (P < 0.01; 
Figure 3, A and B). The shedding of VSMCs surrounding SAs is 
associated with localized degradation of the ECM, a process in 
which the cathepsin family of proteases has been shown to play a 
predominant role (10, 38). As expected, SAs from Adm+/+ placentas 
were tightly surrounded by a prominent band of cathepsin stain-
ing, whereas cathepsin staining was weak and diffuse through-
out the deciduas of Adm–/– placentas and did not surround the 
maternal SAs (Figure 3C), consistent with a failure of these SAs 
to shed their smooth muscle coverage. The enlargement of mater-
nal SAs at midgestation is also associated with proliferation of 
vascular endothelial cells, a process termed reendothelialization. 
Using BrdU incorporation assays, we readily observed this robust 
endothelial cell proliferation in all SAs of Adm+/+ placentas, but 
this was rarely evident in the SAs of Adm–/– placentas (Figure 3D).
Numerous studies have pointed to maternal uNK cells as essen-
tial mediators of SA remodeling, and the precise factors contribut-
ing to their recruitment, activation, and function remains an area 
of intense study. Therefore, we stained and counted the number 
of uNK cells using 2 different uNK markers that identify mature 
(perforin-containing) and/or activated (Ly49G2+) uNK cells. Con-
sistent with the phenotype of failed SA remodeling, we found that 
deciduas of Adm–/– placentas had half the number of perforin-
containing uNK cells observed in Adm+/+ littermates (P < 0.05; 
Figure 3, E and F). Similarly, levels of Ly49G2+ uNK cells were also 
reduced by approximately half in Adm–/– placentas, although the 
difference did not reach statistical significance.
Taken together, our findings demonstrated that lack of fetal AM 
caused numerous placental pathologies, including reduced fetal 
vessel branching, failed SA remodeling, and reduced number of 
uNK cells. We also noted that the incidence and degree of the Adm–/– 
placental phenotype was strictly and exclusively correlated with 
the genotype of the individual Adm–/– conceptus, not influenced 
by the genotype of neighboring conceptuses.
Adm–/– placental phenotype is independent of maternal genotype. A con-
founding factor to the present findings is that the maternal geno-
type used in the above studies was haploinsufficient for AM; we have 
Figure 3
Fetal Adm dosage influences maternal SA remodeling and placental uNK cell content. (A) Anti–α-SMA staining showed that decidual SAs of 
E13.5 Adm–/– placentas retained thick coverage of VSMCs (arrowheads) compared with those of Adm+/+ littermates. (B) Morphometric analysis 
showed a statistically significant increase in the thickness of SMA staining surrounding the SAs of Adm–/– versus littermate Adm+/+ placentas. 
*P < 0.01. (C) Cathepsin staining of decidual SAs. (D) BrdU incorporation assays showed marked proliferation of vascular endothelial cells (arrow-
heads) in all SAs of Adm+/+ placentas, but this was rarely evident in SAs of Adm–/– placentas. (E) Perforin staining of uNK cells within deciduas 
at E13.5. (F) Quantitation of perforin+ uNK cells showed a significant reduction in Adm–/– versus Adm+/+ placentas. *P < 0.05. For all analyses, 
n = 10 placentas per genotype. Scale bars: 50 μM.
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previously shown that during early gestation, Adm+/– females exhibit 
reduced fertility due to abnormal implantation (30, 31). To elimi-
nate this confounding factor, we performed ovary transplantations 
in which Adm+/+ ovaries or Adm+/– ovaries (containing gene-targeted 
Adm-null gametes) were transplanted into WT recipient females 
(referred to herein as Adm+/+ ovary→WT or Adm+/– ovary→WT recipi-
ents, respectively), which were then bred to Adm+/– males (Figure 4A). 
This approach allowed us to evaluate the consequences of loss of 
fetal AM within the context of a WT maternal uterus and immune 
system and to circumvent the inherently low offspring resulting 
from embryo transfer approaches that we previously experienced 
with the 129S6/SvEv strain (30). The average success rate of ovar-
ian transplants (the percentage of pregnant mice relative to the total 
undergoing transplantation) was 57.5% and did not differ based on 
recipient or donor genotype. The transplanted ovaries exhibited 
overtly normal histology, with numerous ovarian follicles and cor-
pora lutea (Supplemental Figure 4), suggestive of normal estrogenic 
function. In addition, compared with Adm+/+ donor ovaries, Adm+/– 
donor ovaries did not adversely affect the recipient females’ breeding 
fecundity, since both exhibited similar recovery times to first partu-
rition (Adm+/+ ovary→WT recipients, 56.3 days; Adm+/– ovary→WT 
recipients, 50.6 days; Figure 4C) and similar litter sizes (Figure 4D).
Figure 4
Ovary transplantation reveals independence of maternal genotype on Adm–/– placental phenotype. (A) Ovary transplantation protocol. Donor 
ovaries from Adm+/– or Adm+/+ female mice were surgically sutured in the ovarian bursa of WT 129S6/SvEv recipient mice after removal of their 
own ovaries. The recipient females were then bred to Adm+/– male mice to generate Adm+/+, Adm+/–, or Adm–/– offspring. (B) Mendelian ratios 
of offspring were as expected, and Adm–/– mice exhibited characteristic embryonic edema (arrowhead) at E13.5. (C and D) Recovery time to 
first parturition (C) and average litter size (D). Numbers within bars denote total number of litters analyzed per breeding. (E–I) Adm–/– placentas 
from Adm+/– ovary→WT recipient females displayed the same pathological phenotypes of Adm–/– placentas from Adm+/– females — including 
(E) reduced fetal vessel branching in the labyrinth, (F) retention of SMCs (arrowheads) around maternal SAs, (G) reduction in endothelial cell 
proliferation (arrowheads) in maternal SAs, and (H and I) significantly reduced DBA+ uNK cell numbers — compared with Adm+/+ littermates. 
*P < 0.05. For ovary transplant studies, n = 6–10 placentas per genotype. Scale bars: 50 μM.
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The cross of Adm+/– males to Adm+/– ovary→WT recipient females 
resulted in the expected Mendelian ratio of fetal genotypes and the 
previously characterized phenotype of extreme embryonic edema 
and lethality for Adm–/– fetuses (Figure 4B and refs. 36, 39). Consis-
tently, the placental phenotypes of underbranched fetal labyrinth 
vessels, poorly remodeled SAs, and significantly reduced uNK cell 
numbers were completely recapitulated in Adm–/– placentas born 
to Adm+/– ovary→WT recipient females compared with Adm+/+ 
littermate placentas and Adm+/+ placentas derived from Adm+/+ 
ovary→WT recipient females (Figure 4, E–I). Thus, loss of Adm from 
fetal tissues directly contributed to the observed placental patholo-
gies, even in the context of genotypically normal maternal Adm.
Recapitulation of phenotypes in placentas genetically lacking the AM 
receptor. AM peptide can bind to and signal through the G pro-
tein–coupled receptor calcitonin receptor–like receptor (Calcrl; 
encoding CLR). We have previously shown that mice with genetic 
deletion of Calcrl phenotypically recapitulate the embryonic lethal-
ity and lymphatic vascular defects observed in Adm–/– mice (36, 40), 
thereby providing genetic and in vivo evidence to substantiate CLR 
as a bona fide AM receptor.
Figure 5
Fetal loss of Calcrl recapitulates Adm–/– placental phenotypes. (A) In situ hybridization of Calcrl gene expression in WT E9.5 mouse placentas 
revealed expression in parietal TGCs, similar to the pattern of Adm expression. Unlike Adm, Calcrl was expressed at moderate levels in the 
embryo and fetal membranes. There was also robust expression of Calcrl in cord-like structures throughout the early decidua. (B) Digital zoom 
of boxed region in A (enlarged ×2-fold), showing punctuate Calcrl staining in TGCs lining the ectoplacental cone at the innermost border of the 
maternal-fetal interface and little to no expression in the chorionic plate. (C) Calcrl expression was diffuse throughout the labyrinth at E13.5 and 
robustly expressed in the maternal endothelial cells lining the decidual SAs (arrows, inset; enlarged ×2-fold). (D) H&E staining of placentas from 
Calcrl+/+ and Calcrl–/– littermates revealed largely normal structures, with no appreciable differences in layers. Digital zoom of central part of pla-
centas is shown at the right of each image (enlarged ×1.5-fold). (E–H) Calcrl–/– placentas at E13.5 displayed the same pathological phenotypes of 
Adm–/– placentas — including (E) reduced fetal vessel branching in the labyrinth, as visualized by isolectin staining, (F) retention of SMCs around 
maternal SAs, and (G and H) significantly reduced number of DBA+ uNK cells — compared with Calcrl+/+ littermate placentas. *P < 0.001. n ≥ 6 
placentas analyzed per genotype. Data are mean ± SEM. Original magnification, ×4 (A–C). Scale bars: 1 mm (D); 50 μM (E and G); 10 μM (F).
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Figure 6
Genetic overexpression of fetal Adm reverses the placental preeclampsia phenotypes and drives uNK recruitment to the decidua. (A) Targeting vector 
for generation of Admhi/hi mice consisted of (a) a 6-kb genomic fragment of the Adm gene isolated from a 129S6/SvEv genomic phage library and 
containing all 4 exons and 5′UTR and 3′UTR of the Adm gene, (b) the bovine growth hormone polyA sequence (bGH 3′UTR), (c) 2 tandem copies 
of the 1.2-kb 5′ insulator sequence from chicken β-globin gene (2XIns), (d) 1.3 kb of pMC1 promoter–driven neomycin (Neo), (e) 80 bp of AU/U-rich 
element of the mouse c-fos gene (ARE), and (f) 2 loxP recombination sites. The latter 5 elements were cloned as a cassette, 23 bp downstream of the 
endogenous Adm stop codon. (B) Southern blot analysis on genomic DNA confirmed correct targeting of the Admhi allele. (C) Adm gene expression 
in placentas from Adm+/+ and Admhi/hi mice, analyzed by quantitative RT-PCR, showed a significant 3-fold increase in gene expression level. *P < 0.05. 
(D–G) Admhi/hi placentas (D) appeared histologically comparable to Adm+/+ placentas and showed (E) highly branched fetal labyrinth vessels, (F) 
appropriate SA remodeling, and (G) reendothelialization. (H and I) DBA staining revealed that Admhi/hi placentas had a significant 30% increase in 
uNK cell numbers compared with Adm+/+ littermate placentas. *P < 0.05. Data are mean ± SEM. Scale bars: 1 mm (D); 50 μM (E–H).
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Using in situ hybridization, we consistently found high levels 
of Calcrl expression in WT placentas that spatially and temporally 
colocalized with that of the peptide ligand Adm. Specifically, Calcrl 
expression was robustly present in parietal TGCs at both E9.5 and 
E13.5 (Figure 5, A–C). In contrast to the diffuse expression of Adm 
surrounding the ectoplacental cone and stromal decidual cells, 
expression of Calcrl was concentrated to endothelial-like cords of 
the E9.5 decidua (41) and to maternal endothelial cells lining the 
maternal SAs of E13.5 placentas (Figure 5C, inset).
Like Adm–/– placentas, the Calcrl–/– placentas appeared overtly 
normal and contained well-formed placental layers and nor-
mal histomorphometric features (Figure 5D). Nevertheless, the 
Calcrl–/– placentas exhibited the same abnormal phenotypes 
of Adm–/– placentas, including reduced fetal vessel branching, 
retention of SMCs surrounding maternal SAs, and significantly 
reduced uNK cell numbers compared with Calcrl+/+ littermate 
placentas (Figure 5, E–H). Thus, the recapitulation of the Adm–/– 
placental phenotype in Calcrl–/– placentas further supports the 
role of CLR as an AM receptor within this tissue and indicates 
that lack of AM signaling within the fetal compartment is caus-
ally associated with these phenotypes.
Overexpression of fetal Adm reverses the placental phenotype and drives 
maternal uNK cell recruitment to the decidua. The absence of apoptosis 
within decidual regions that contain uNK cells (Figure 1E) sug-
gests that the reduced number of uNK cells in Adm–/– placentas 
may be caused by abnormalities in their recruitment to the tissue, 
rather than their loss through cell death. To determine whether 
fetal AM can directly influence the recruitment of uNK cells to 
the decidua, we generated and characterized a novel gene-targeted 
mouse model in which AM expression was increased approxi-
mately 3-fold (Figure 6, A–C). The gene targeting was designed to 
increase AM expression approximately 3-fold via stabilization of 
mRNA levels through genetic modification of the 3′ untranslated 
region (3′UTR) of the endogenous Adm gene.
Adm+/hi mice were viable and fertile and were intercrossed in order 
to compare placental phenotypes between Adm+/+ and Admhi/hi 
littermates. The average litter size of Admhi/hi females was 6.04 live 
births, which was not significantly different than the 6.60 pups per 
litter observed for WT C57BL/6J mice of the comparable genetic 
background. Admhi/hi placentas born to Adm+/hi intercrossed mice 
appeared overtly normal and had appropriately branched laby-
rinth fetal vessels that were indistinguishable from Adm+/+ litter-
mates (Figure 6, D and E). Moreover, the SAs of Admhi/hi placentas 
were appropriately remodeled and did not differ from those of 
Adm+/+ littermates (Figure 6, F and G). Interestingly, Dolichos biflorus 
agglutinin (DBA) staining and counting of uNK cells revealed that 
Admhi/hi placentas had a significant 30% increase in the number of 
uNK cells within the decidua compared with that of Adm+/+ litter-
mate placentas (Figure 6, H and I). These data indicate that 3-fold 
overexpression of Adm is compatible with normal placental devel-
Figure 7
AM is a direct activator of uNK cells in vivo and in vitro. (A) Using a mouse Chemokines and Receptors array platform (see Methods), the 
expression of 85 chemokines, cytokines, and related proteins was evaluated in placental RNA extracts from Adm–/–, Admhi/hi, and respective WT 
littermates. Admhi/hi placentas showed significant elevations in numerous cytokines and chemokines that were concomitantly downregulated in 
Adm–/– placentas. *P < 0.05. (B) uNK cells isolated from E10.5–E12.5 WT placentas were cultured in vitro and treated with 10 nM AM. Screening 
for more than 25 chemokines and cytokines from media samples revealed significant 2- to 4-fold increases in secretion of numerous chemokines 
and cytokines and a prominent reduction in the secretion of CCL5, IL-16, and IL-23 in response to AM treatment. All changes were statistically 
significant compared with untreated control (P < 0.05). (C) Isolated WT uNK cells exhibited dose-dependent increases in Mmp9 gene expression, 
which (D and E) correlated with increased MMP9 zymography activity. Mmp2 gene expression levels and zymography activity were not affected 
by AM treatment. *P < 0.05.
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opment and, moreover, that fetal-derived AM can actively promote 
the recruitment of uNK cells to the placenta.
AM dose-dependently alters the chemokine, cytokine, and MMP profiles of 
uNK cells in vivo and in vitro. uNK cells constitute the largest propor-
tion of immune cells in the decidua, and so we expected and found 
that the dynamic fluctuations in uNK cell recruitment between 
Adm–/– and Admhi/hi placentas were reflected by concomitant 
changes in the expression of numerous chemokines and cytokines. 
Specifically, the expression of Ccl7, Ccl17, Cxcl9, Cxcl10, Xcl1, and 
TNF were downregulated in Adm–/– placentas and concomitantly 
upregulated in Admhi/hi placentas compared with their respec-
tive WT controls (Figure 7A). To determine whether AM peptide 
directly causes secretion of chemokines and cytokines from 
uNK cells, we isolated uNK cells and first determined that these 
cells expressed high levels of Calcrl and survived up to 48 hours 
in culture without evidence of apoptosis, as evaluated by TUNEL 
and trypan blue exclusion (Supplemental Figure 5 and data not 
shown). Then, using a Luminex-based detection system, we found 
that treatment of uNK cells with 10 nM AM stimulated marked 
secretion of a variety of chemokines and cytokines (Figure 7B), sev-
eral of which have established functions in reproductive immu-
nology (i.e., CXCL10, GM-CSF, and IL-23) (42). Furthermore, we 
found that AM treatment dose-dependently increased the gene 
expression and activity of MMP9, but not MMP2, in uNK cells 
(Figure 7, C–E), consistent with the previously described func-
tions of uNK-derived MMP9 in SA remodeling (43). Collectively, 
these data suggest that fetal-derived AM potently influences the 
immune milieu of the placenta in 2 ways: first by recruiting, then 
by activating, uNK cells to secrete chemokines, cytokines, and 
MMPs, which are important contributors to SA remodeling.
AM-treated uNK cells stimulate VSMC apoptosis. Finally, we sought 
to determine whether the effects of AM on isolated uNK cells 
directly relate to the phenotype of reduced SA remodeling in 
Adm–/– placentas. To test this, we developed an in vitro cell culture 
system in which primary mouse VSMCs were treated with control 
media or uNK-conditioned media that had been supplemented or 
not with 10 nM AM peptide. As predicted, treatment of VSMCs 
with control media and AM-supplemented control media had no 
obvious effects on cell growth, morphology, or apoptosis (Figure 8, 
A and B). In contrast, treatment of VSMCs with uNK-conditioned 
media resulted in dramatic changes in cellular morphology and 
apoptosis rate. Importantly, these effects were markedly and signif-
icantly exacerbated when the uNK-conditioned media was supple-
mented with AM, with a nearly 4-fold increase in the ratio of pro-
apoptotic Bax to antiapoptotic Bcl2 gene expression (Figure 8C). 
Thus, we conclude that AM can promote the secretion of a cock-
tail of chemokines and cytokines from uNK cells that can in turn 
induce apoptosis of VSMCs.
Discussion
Using both loss-of-function and gain-of-function genetic mouse 
models, we found that fetal AM, acting through CLR, serves as a tro-
phoblast-derived factor critical for fetal placental vascularization 
and for the maternal vascular adaptation to pregnancy (Figure 9). 
There were several pleiotropic consequences of absent AM/CLR sig-
naling within the trophoblast compartment, which could be diffi-
cult to causally distinguish from one another. However, the precise 
replication of the Adm–/– phenotype in Calcrl–/– placentas dem-
onstrated that the predominant factor in initiating the complex 
phenotype is the absence of ligand signaling and secretion in the 
trophoblast cell. Ultimately, the mechanisms of AM action appear 
to be largely mediated through its local effects on the decidual 
content and activation of maternal uNK cells, which in our experi-
ments expressed either WT or hemizygous levels of CLR. Therefore, 
the phenotypes associated with Adm–/– and Calcrl–/– placentas, and 
their reversal by Adm overexpression, demonstrated that the dosage 
of AM provided by the fetus is a critical communication factor that 
has a profound effect on the innate immune milieu of the placenta.
It is worth noting that nearly all of the characteristic features 
of Adm–/– and Calcrl–/– placentas were similar to the pathologi-
cal features that have been characterized in human preeclampsia. 
Although it is imperative to consider the anatomical and func-
Figure 8
Conditioned media from AM-treated 
uNK cells causes VSMC apoptosis.  
(A and B) Confluent monolayers of 
cultured mouse VSMCs were placed 
for 12 hours in control media or uNK-
conditioned media treated or not 
with 10 nM AM peptide, then imaged 
(A) and stained with TUNEL (B). (C) 
After treatment with uNK-conditioned 
media, expression levels of the pro-
apoptotic Bax and antiapoptotic Bcl2 
genes were analyzed from VSMC RNA 
lysates by quantitative RT-PCR; data are 
expressed as Bax/Bcl2 ratio. *P < 0.05, 
1-way ANOVA. Data are mean ± SEM. 
Original magnification, ×20 (A).
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tation, a much more simplified explanation is likely. Namely, 
Adm–/– fetuses die between E13.5 and E14.5, and so their defec-
tive placentas are resorbed at midgestation, thus precluding 
systemic toxicity to the mother. In addition, since only one-
quarter of the litter was of the Adm–/– genotype, it is unlikely 
that a minority of placentas could induce the presentation of 
overt maternal preeclampsia early in gestation. Future studies 
of genetic deletion of Adm and/or Calcrl exclusively in TGCs may 
help address this shortcoming (50).
Another interesting avenue for future studies will be to deter-
mine the mechanism by which the genetic dosage of fetal-derived 
AM is proportionally related to the number of uNK cells recruited 
to the decidua. A remarkable aspect of these findings is that the 
local dosage of AM peptide within an individual conceptus pro-
foundly influenced decidual uNK cell content compared with a 
neighboring conceptus within the same litter, independent of 
maternal genotype. Therefore, this implies that localized fetal-
derived mechanisms for trafficking and recruitment of uNK cells 
to the decidua must exist. It is worth noting that although AM 
peptide can act as a vasodilator on uterine blood vessels (29), 
and thereby possibly increase localized maternal blood flow and 
uNK cell delivery to the decidua, the more prevalent role of AM 
appears to be on lymphatic vessels. Indeed, global deletion of the 
AM receptor, Calcrl, in adult animals results in a multitude of sys-
temic defects associated with lymphatic dysfunction (51), and we 
and others have consistently shown a preferential and prevalent 
role for AM in regulating lymphatic vessel permeability and pro-
liferation (36, 52, 53). Considering that we are still only beginning 
to understand the complex processes that regulate uNK cell traf-
ficking to the placenta (11, 54), it stands to reason that additional 
studies incorporating the function of uterine and decidual lym-
phatic vessels as conduits for the delivery, maturation, and clear-
ance of immune cells should be explored (55).
Based on the mouse phenotypes presented herein, it will be 
of interest to determine whether perturbations in AM signaling 
during pregnancy in humans might be associated with, or even 
causative of, poor pregnancy outcomes. Numerous studies over 
the past decade have used an assortment of “homemade” and 
commercial kits for the measurement of plasma AM levels dur-
ing human pregnancy. While there has been general concordance 
among studies that AM is elevated during a normal pregnancy, 
but blunted in preeclampsia, there has also been significant varia-
tion among studies, due to the inherently poor stability of AM 
peptide and differences in assays used (reviewed in ref. 23). How-
ever, measurement of the highly stable peptide hormone precursor 
of AM, midregional proadrenomedullin (MR-proAM), can now be 
performed with such a high level of accuracy that it is showing 
great clinical value in the context of predicting poor outcomes 
after myocardial infarction, sepsis, and community-acquired 
pneumonia (56). Therefore, reevaluation of plasma AM levels dur-
ing pregnancy and in complications of pregnancy using these new 
technological advances is warranted. In addition, these data can be 
linked to recent findings revealing several SNPs in the human Adm 
gene (some of which correlate directly with plasma AM levels) that 
are associated with hypertension and proteinuria (57, 58).
An inherent caveat to these types of clinical studies, which is 
somewhat incongruent with our current model, is that they are 
often focused on maternal plasma levels and genotype (albeit by 
necessity). Our data clearly demonstrated that the fetal levels and 
genotype of Adm were the critical determinants of its function at 
tional differences between placentas of humans and mice (44–46), 
the reduction in fetal vascular branching, failed SA remodeling, 
and lack of SA reendothelialization we describe here have long 
been associated with preeclampsia in humans (47). More recently, 
additional studies demonstrating deregulation of uNK cells and 
the levels of placental chemokines and cytokines have also been 
appreciated in human preeclampsia (20, 22). Finally, some of the 
most clinically relevant breakthroughs in recent years have been 
discoveries of numerous angiogenic factors and their soluble 
receptors as predictive biomarkers of preeclampsia, including 
soluble Fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin 
(sEng) (48). In this regard, it is important to appreciate that AM 
signaling — by virtue of its regulation by hypoxia, high levels of 
receptor expression in endothelium, and requirement for vascular 
development — serves as an additional and powerful angiogenic 
factor within the placenta, with potential importance in the path-
ological presentation of preeclampsia.
An obvious question that extends from these findings is 
whether Adm+/– dams exhibit the maternal systemic symptoms 
of preeclampsia, including elevated blood pressure and protein-
uria, as a result of renal dysfunction. In fact, our data demon-
strated that Adm+/– dams did not exhibit overt preeclampsia. 
Using telemetric recordings of maternal blood pressure, we 
found no significant differences in basal blood pressure between 
pregnant Adm+/– and WT control dams throughout gestation 
(49), and there were also no differences in urine protein levels 
during late gestation (data not shown). Although an explana-
tion for a lack of maternal preeclampsia in Adm+/– dams could 
be built around the differences between mouse and human ges-
Figure 9
Model of fetal-derived AM action at the maternal-fetal interface. AM 
and its G protein–coupled receptor, CLR, are highly expressed in pari-
etal TGCs at the maternal-fetal interface at midgestation. The genetic 
dosage of fetal AM is directly proportional to the content of maternal 
uNK cells and their secreted chemokines, cytokines, and MMPs within 
the placenta. As a consequence, AM expression in fetal trophoblast 
cells is necessary for appropriate branching of the fetal vasculature 
and remodeling of maternal SAs. Overexpression of AM within the fetal 
compartment is sufficient to promote uNK recruitment and activation in 
the decidua, a process that likely contributes to AM-induced activation 
of MMP9 and maternal SA remodeling.
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Doppler ultrasound. Intravital Doppler ultrasound was performed on anes-
thetized female mice at E12.5 using the VisualSonics Vevo 770 system with 
a 40-MHz probe. Placental impedance was calculated from umbilical cord 
waveforms by dividing the arterial venous delay by the cycle length.
Placental vascular corrosion casting and scanning electron microscopy. Vascular 
corrosion casting of E13.5 Adm+/+ and Adm–/– placentas from littermates 
of Adm+/– male and female intercrosses were performed as previously 
described (68). The castings were processed for scanning electron micros-
copy as previously described (30) and were viewed and photographed with 
a Cambridge Stereoscan S200 scanning electron microscope (LEO Electron 
Microscopy Inc.) using an accelerating voltage of 20 kV.
In situ hybridization. In situ hybridization was performed as previ-
ously described (30) using nonradioactive in situ hybridization reagents 
(1745816, 1585762, 1093274; Roche Diagnostics).
Cytokine expression arrays and cytokine antibody array. RNA was extracted 
from whole placentas using TRIzol reagent (15596-026; Invitrogen) and 
purified with Qiagen RNeasy Mini Kit (74104; Qiagen). cDNA was made 
using the RT First Strand Kit (C-03; SABiosciences), and cytokine expres-
sion was determined using RT Profiler PCR Array System for Mouse Che-
mokines and Receptors (PAMM-022A-2; SABiosciences). Data were ana-
lyzed using the ΔΔCt method. Analysis for the simultaneous detection of 
cytokines and chemokines was performed with the Cytokine Antibody 
Array I (ARY006; R&D) following the manufacturer’s instructions.
TUNEL and BrdU staining. TUNEL in situ cell death detection kit (1 684 
795; Roche Applied Science) was used to identify apoptotic cells. Cell pro-
liferation was marked with a single intraperitoneal injection of 100 mg 
BrdU per kilogram body weight (B9285; Sigma-Aldrich). BrdU Staining 
kit (93-3943; Zymed) was used to detect BrdU+ cells, which were quantified 
using Image J software.
uNK cell isolation and culture of primary aortic VSMCs. uNK cells were iso-
lated as previously described using the Dynal CELLection Biotin Binder 
Kit (115.33D; Dynal) in conjunction with biotinylated DBA lectin (L6533; 
Sigma-Aldrich) (17). Isolated uNK cells were cultured in complete RPMI 
media with 10% FCS for 24 hours and then supplemented with 10 nM AM 
or PBS vehicle. Cells and media were collected for analysis 24–48 hours 
after isolation. Aortic VSMCs were isolated from C57BL/6J mice and cul-
tured as described previously (69).
Immunohistochemical antibodies. Antibodies were as follows: anti–α-SMA 
(A2547; Sigma-Aldrich), anti-perforin (804-057-C100; Alexis Biochemi-
cals), Ly49G2+ (55-5314; BD Biosciences — Pharmingen), anti–placental 
alkaline phosphatase (CBL207; Millipore), cathepsin S M-19 (6505; Santa 
Cruz), FITC-conjugated isolectin B4 (L2895; Sigma-Aldrich), FITC-conju-
gated DBA lectin (L9142; Sigma-Aldrich).
Statistics. In all figures, data are presented as mean ± SEM. Statistical 
analyses were performed with JMP software (SAS). 2-tailed Student’s t test 
was used to compare 2 groups; 1-way ANOVA was used to compare more 
than 2 groups. A P value less than 0.05 was considered significant. Exact 
P values and n for each experiment are provided in the figure legends.
Study approval. All experiments using animals were approved by the Insti-
tutional Animal Care and Use Committee of The University of North Caro-
lina at Chapel Hill.
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the maternal-fetal interface. Therefore, it becomes of importance 
to identify genetic, physiological, and/or environmental factors 
that regulate Adm expression within the fetal trophoblast cell. It 
has long been appreciated that estrogen and hypoxia can potent-
ly upregulate Adm expression in a variety of cell types, including 
those of reproductive relevance (24, 59). Most interestingly, it has 
recently become clear that cigarette smoke, likely acting through 
2 functional xenobiotic response elements proximal to the Adm 
start codon (60), can also potently induce Adm expression in tro-
phoblast cells (61). Moreover, exposure of humans and mice to 
cigarette smoke during pregnancy has recently been linked to a 
statistically significant increase in uNK cell numbers (62). Thus, 
although cigarette smoking during pregnancy has a wide range of 
deleterious effects, the cigarette smoke–induced upregulation of 
Adm expression in fetal trophoblast cells, and the potential sub-
sequent increase in uNK cells, may provide the mechanistic link 
for explaining the decades-old clinical observation that moder-
ate smoking during pregnancy is actually protective against pre-
eclampsia (63, 64).
In summary, our present findings revealed a critical function 
for a fetal-derived trophoblast factor in the maternal adaptation 
to pregnancy. The increased clinical usage of MR-proAM plasma 
levels as a biomarker for a variety of cardiovascular conditions 
underscores the importance of exploring AM as a biomarker for 
preeclampsia. Because CLR is already being exploited as a pharma-
cological target for the treatment of migraine (65, 66), it is conceiv-
able that direct targeting of the AM/CLR axis may hold tremen-
dous clinical benefit for the amelioration of pregnancy outcomes.
Methods
Mice. Generation of mice with a targeted, homozygous deletion of the Adm 
and Calcrl genes has been previously described (39, 40). These mice were 
maintained on an isogenic 129S6/SvEv background.
Admhi/hi mice were generated by standard gene targeting protocols. The 
endogenous 3′UTR of the Adm gene was replaced with a cassette (parts of 
which were provided by M. Kakoki, The University of North Carolina at 
Chapel Hill) containing the bovine growth hormone UTR (bGH 3′UTR) in 
E14 ES cells. Southern blot analysis was performed by digesting genomic 
DNA with BamHI, which revealed an 11.4-kb fragment representing the 
WT allele and a 3.9-kb fragment corresponding to the Admhi allele. Sev-
eral chimeric animals were generated, and germline transmission of the 
targeted allele was established on a mixed genetic background. F1 het-
erozygotes from male chimera–to–female C57BL/6J breedings were back-
crossed to C57BL/6J for more than 10 generations. Routine genotyping of 
the Admhi allele was performed by a 3-primer, PCR-based strategy (primer 
1, 5′-AACCTTACACCTTGCTGAGACATTC-3′; primer 2, 5′-TTTATTAG-
GAAAGGACAGTGGGAGTG-3′; primer 3, 5′-CCCACATTCGTGTCAAAC-
GCTAC-3′). Primers 1 and 3 amplify a 760-bp WT allele, while primers 2 
and 3 amplify a 600-bp targeted allele.
For timed pregnancies, heterozygous male and female Adm+/– or Adm+/hi 
intercrosses were established, and the day when the vaginal plug was detect-
ed was considered E0.5. Fetal genotypes were determined by established 
allele-specific, PCR-based assays (39, 40) using genomic DNA isolated from 
fetal membranes or tail biopsies.
Ovary transplantation. Ovary transplantation experiments were performed as 
previously described (67) using donor and recipient animals 8–16 weeks old 
on the 129S6/SvEv genetic background. Hemiovaries from Adm+/– or Adm+/+ 
mice were surgically sutured into the ovarian bursa of recipient WT mice after 
bilateral removal of the recipient’s own ovaries. 2 weeks after surgery, Adm+/– 
ovary→WT and Adm+/+ ovary→WT recipients were used in experiments.
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